Darshan Pharmacuticals Private Limited
Darshan Pharmacuticals Private Limited is a Private Indian company incorporated in 2010 and based in Maharashtra, India. Darshan Pharmacuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Explore the financials, board members, legal insights, and much more in the complete profile of Darshan Pharmacuticals Private Limited.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Darshan Pharmacuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +29d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Darshan Pharmacuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 315081041 | State Bank of India(Bank) | ₹21.49 Cr | 19 Sep 2021 | Open |
| 282249184 | ICICI Bank Ltd(Bank) | ₹8.00 Cr | 12 Mar 2021 | Satisfied |
| 677713802 | Kotak Mahindra Bank Ltd(Bank) | ₹10.77 Cr | 04 Jul 2023 | Satisfied |
| 277299830 | Axis Bank Ltd(Bank) | ₹8.06 Cr | 04 Jul 2021 | Open |
| 126943560 | State Bank of India(Bank) | ₹20.26 Cr | 12 Mar 2019 | Satisfied |
Charge IDs, lenders & amounts for Darshan Pharmacuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹68.40 Cr | ₹1.17 Cr | ₹28.38 Cr | ₹69.74 Cr | 171 |
| FY2023-24 | ₹58.08 Cr | ₹1.58 Cr | ₹33.17 Cr | ₹95.54 Cr | 86 |
| FY2022-23 | ₹52.93 Cr | ₹1.50 Cr | ₹46.45 Cr | ₹73.92 Cr | 251 |
| FY2021-22 | ₹43.26 Cr | ₹99.53 L | ₹21.58 Cr | ₹60.70 Cr | 142 |
Audited financials & ratios for Darshan Pharmacuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹68.40 Cr | ₹58.08 Cr | ₹52.93 Cr | ₹43.26 Cr |
| Other income | ₹1.43 Cr | ₹1.12 Cr | ₹1.20 Cr | ₹63.61 L |
| Total income | ₹69.83 Cr | ₹59.20 Cr | ₹54.12 Cr | ₹43.90 Cr |
| Total expenses | ₹68.34 Cr | ₹57.18 Cr | ₹52.21 Cr | ₹42.62 Cr |
| Profit before tax | ₹1.52 Cr | ₹2.05 Cr | ₹1.94 Cr | ₹1.29 Cr |
| Profit / (Loss) after tax | ₹1.17 Cr | ₹1.58 Cr | ₹1.50 Cr | ₹99.53 L |
| Balance sheet | ||||
| Equity / Net worth | ₹28.38 Cr | ₹33.17 Cr | ₹46.45 Cr | ₹21.58 Cr |
| Borrowings | ₹13.70 Cr | ₹20.43 Cr | ₹10.00 Cr | ₹20.31 Cr |
| Current liabilities | ₹20.79 Cr | ₹18.76 Cr | ₹16.24 Cr | ₹22.93 Cr |
| Total liabilities | ₹41.36 Cr | ₹62.37 Cr | ₹27.47 Cr | ₹39.12 Cr |
| Current assets | ₹38.85 Cr | ₹37.55 Cr | ₹27.23 Cr | ₹35.09 Cr |
| Cash & equivalents | ₹14.30 Cr | ₹12.75 Cr | ₹8.82 Cr | ₹12.24 Cr |
| Total assets | ₹69.74 Cr | ₹95.54 Cr | ₹73.92 Cr | ₹60.70 Cr |
| Employees | 171 | 86 | 251 | 142 |
Audited financials & ratios for Darshan Pharmacuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹68.40 Cr | -6.3% | -2.8% | +9.4% |
| Profit after Tax | ₹1.17 Cr | -0.4% | +17.0% | +17.1% |
| Net Worth | ₹28.38 Cr | +3.7% | +15.4% | +3.7% |
| Employees | 171 | +1.6% | -3.0% | +16.4% |
Audited financials & ratios for Darshan Pharmacuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹68.40 Cr | ₹1.17 Cr | +1.71% | +29.07% | +4.11% | +1.67% | 0.48 | ₹40.00 L |
| FY2023-24 | ₹58.08 Cr | ₹1.58 Cr | +2.72% | -5.00% | +4.76% | +1.65% | 0.62 | ₹67.54 L |
| FY2022-23 | ₹52.93 Cr | ₹1.50 Cr | +2.82% | +25.25% | +3.22% | +2.02% | 0.22 | ₹21.09 L |
| FY2021-22 | ₹43.26 Cr | ₹99.53 L | +2.30% | +37.60% | +4.61% | +1.64% | 0.94 | ₹30.47 L |
Audited financials & ratios for Darshan Pharmacuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,67,42,797 | 61.39% |
| Institutional Investors | 2 | 47,77,099 | 10.97% |
| Public & Others | 39 | 1,20,45,674 | 27.65% |
Promoter, institutional & public holding for Darshan Pharmacuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
121 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.